Thyroid : official journal of the American Thyroid Association
Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?
Suyoung Choi, Sarthak Vinay Shah, Patcharaporn Chandraparnik, Karen Michelle Wai, Ehsan Rahimy, Euna Koo, Chase A Ludwig, Farzad Pakdel, Chrysoula Dosiou, Prithvi Mruthyunjaya, Andrea L Kossler
Published: 202510.1177/10507256251408731
Abstract
Background: The treatment paradigm for thyroid eye disease (TED) in the United States has shifted from corticosteroids toward targeted therapies such as teprotumumab. However, it remains unknown whether teprotumumab decreases the need for subsequent…
Preview only. Read the full abstract at the source